Next Article in Journal
Emerging Roles of Sonic Hedgehog in Adult Neurological Diseases: Neurogenesis and Beyond
Next Article in Special Issue
Natural Products for the Treatment of Autoimmune Arthritis: Their Mechanisms of Action, Targeted Delivery, and Interplay with the Host Microbiome
Previous Article in Journal
Enhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents
Previous Article in Special Issue
Novel Therapeutic Agent against Platelet Activation In Vitro and Arterial Thrombosis In Vivo by Morin Hydrate
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 19
Issue 8
10.3390/ijms19082422
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prenylated Flavonoids from Roots of Glycyrrhiza uralensis Induce Differentiation of B16-F10 Melanoma Cells

by
Yunfeng Zheng
1,
Huaiyou Wang
2,3,
Min Yang
1,
Guoping Peng
1,
Tina Ting Xia Dong
2,3,
Miranda Li Xu
2,3 and
Karl Wah Keung Tsim
2,3,*
1
School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
2
Division of Life Science and Center for Chinese Medicine, The Hong Kong University of Science and Technology, Hong Kong 999077, China
3
Shenzhen Key Laboratory of Edible and Medicinal Bioresources, The Hong Kong University of Science and Technology Shenzhen Research Institute, Hi-Tech Park, Shenzhen 518057, China
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(8), 2422; https://doi.org/10.3390/ijms19082422
Received: 12 July 2018 / Revised: 7 August 2018 / Accepted: 8 August 2018 / Published: 16 August 2018
(This article belongs to the Special Issue Plant Natural Products for Human Health)
Browse Figures
Versions Notes

Abstract

:
Roots of Glycyrrhiza uralensis have been used as herbal medicine and natural sweetener. By activity-guided phytochemical investigation of the extracts from G. uralensis root, ten flavonoids, namely GF-1–GF-10, of which five were prenylated flavonoids, were found to show antiproliferative effects in melanoma B16-F10 cells. Three of the prenylated flavonoids, namely GF-1, GF-4 and GF-9, significantly induced the differentiation of B16-F10 cells; the inductions included increase of tyrosinase activity, tyrosinase protein, and melanin content. In GF-1 and GF-9 induced melanoma differentiation, the phosphorylation of p38 MAPK (mitogen activated potein kinase) was identified; while GF-4 could trigger the phosphorylation of PI3K/AKT (phosphatidylinositol 3-kinase/Protein Kinase B) signaling. However, application of GF-6 to the melanoma cells did not induce differentiation; but which promoted cell apoptotic signaling, i.e., increase levels of cleaved-PRAP, cleaved-caspase 3, and cleaved-caspase 9. These results suggested that different types of prenylated flavonoids from G. uralensis might have potential anticancer effects against melanoma cells by acting through different signaling pathways.

Graphical Abstract

1. Introduction

The roots of Glycyrrhiza uralensis Fisch (GlycyrrhizaeUralensis Radix; GUR), named as licorice or gancao, have been extensively used as a herbal drug in both Eastern and Western countries [1]. Clinical studies have shown GUR is highly effective in the treatment of respiratory, gastrointestinal, cardiovascular and genitourinary conditions [2]. According to traditional Chinese medicine (TCM) theory, GUR is described as a beneficial herb to enhance therapeutic effects; meanwhile, this herb is being employed commonly to detoxify potential adverse effects in many herbal mixtures during clinical application. Phytochemical studies revealed that triterpene saponins and flavonoid glycosides were two major active substances in GUR [3]. In the extractive of GUR, the nonpolar fraction of GUR is rich in various types of prenylated flavonoids, e.g., flavones, isoflavones, flavanones, chalcones, and coumestans [4]. These flavonoids are being considered to be active ingredients of GUR, and indeed which have been commonly used in food industries. In recent pharmacological studies, GUR flavonoids have been proposed to have anti-oxidation [5], anti-inflammatory [6], antiproliferative, and cytotoxic effects in various cells [7]. Despite the aforementioned proposed actions, the roles of GUR prenylated flavonoids in cancer cells have not been extensively investigated.
Malignant melanoma is a highly aggressive and invasive skin cancer with high metastatic potential and extraordinary resistance to cytotoxic agents [8]. The occurrence of melanoma is related to different factors, e.g., sun exposure, fair pigmentation, and genetic mutation [9]. In recent years, the incidence of melanoma is rapidly increasing throughout the world, especially in America and Europe [10]. Although drug therapy for this cancer has been developed rapidly, e.g., immunotherapies with PD-1 inhibition drugs (ipilimumab and nivolumab) and T-cell checkpoint blockade therapies [11,12], the usage of herbal products is still one of the alternative approaches for melanoma cancer treatment.
Considering the pathogenesis and clinical treatment of melanoma, the recent targets in cancer therapy is focusing on discovery of natural products that are able to suppress cancer cell proliferation and promote cell differentiation [13,14]. Here, the CH2Cl2 extract of GUR (GURCH2Cl2) was shown to exhibited potent effect in antiproliferation and inducing differentiation of cultured melanoma B16-F10 cells: these effects were significant higher than that deriving from water extract (GURwater) and ethanol extract of GUR (GUREtOH). To explore the possible underlying mechanism for anticancer effect of GUR, ten flavonoids (GF1-GF10) of which five were prenylated flavonoids, were isolated. The roles of these flavonoids in inducing the differentiation of cultures B16-F10 cells were illustrated, and subsequently the signaling cascades, triggered by various flavonoids, were revealed and compared.

2. Results

2.1. G. uralensis Extracts in Proliferation and Differentiation of Melanoma Cells

Different extractives of GUR, i.e., GUwater, GUEtOH, and GUCH2Cl2, were subjected to HPLC analyses. As shown in HPLC chromatograms (Figure 1A), saponins and flavonoid glycosides were the major constituents in both GUwater (water extract) and GUEtOH (ethanol extract). Besides, a small amount of free flavonoids could be detected in GUEtOH. In comparison with GUwater and GUEtOH, GUCH2Cl2 (dichloromethane extract) exhibited a comparable enrichment of free flavonoids. To a certain extent, difference in chemicals might cause possible difference in their biological capacities.
To investigate the effect of G. uralensis extracts, cultured B16-F10 melanoma cells were treated with different extracts at indicated concentrations for 48 h. As shown in Figure 1B, GUCH2Cl2 inhibited the proliferation of B16-F10 cells with an IC50 value of 48.7 ± 2.5 μg/mL, whereas GUwater and GUEtOH exhibited little effects (IC50 > 100 μg/mL). In addition to the differentiation induction, as shown in Figure 1C, the GUCH2Cl2-treated (50 μg/mL) cells showed typical dendrite-like cellular protrusions, as compared with control cells. Although GUEtOH had a certain degree of differentiation-inducing activity, as compared with the control group, its effect was far lower than that of GUCH2Cl2. Over 40% cells were induced to differentiate under the treatment of GUCH2Cl2 (Figure 1C). Similar to antiproliferative activity, GUwater showed little morphological changes towards cultured B16-F10 cells. These results suggested that free flavonoid content in the extract could be responsible for differentiation and antiproliferation of B16-F10 cells.

2.2. Structure Identification of Isolated Compounds

To explore active compounds in GUR extracts corresponding for activitieson cell differentiation, phytochemical investigation of GUCH2Cl2 was performed, and there after 10 compounds were isolated. Their structures and types were elucidated on the basic of ESI-Q-TOF/MS and 1H and 13C NMR and by comparison with the literatures. The 13C NMR data were presented in Table 1, and the MS and 1H NMR data of each compound were available in the supplementary information.
As shown in Figure 2, all isolated compounds were identified as free flavonoids, including three isoflavones, three flavones, two chalcones, one coumarin, and one flavanone, namely GF-1–GF-10. Compounds GF-1, 2, and 5 were isoflavones, identified as licoisoflavone B, glabrone, and formononetin, respectively. Compounds GF-3, 9, and 10 were classified as flavones and elucidated successively as 7, 4′-dihydroxyflavone, licoflavone, and kumatakenin A, respectively. With the data of NMR and MS, two chalcones, GF-6 and GF-8 were established as licochalcone A and isoliquiritigenin, respectively. GF-4 was identified as a coumarin namely as neoglycyrol, which could be regarded as an isoflavone derivative with methoxyl, hydroxyl, and prenyl groups. GF-7 was identified as a common flavanone, namely as liquiritigenin. The HPLC of isolated flavonoids and dichloromethane extract of G. uralensis were available in the supplementary information. The purities of these ten flavonoids were tested to be higher than 95% by HPLC-UV area normalization method.
In recent years, flavonoids, especially the prenylated ones, have attracted extensive attention because of its resulting radicals can enhance their biological activities [15]. In this study, several flavonoids, including GF-1, 2, 4, 6, and 9, were found to contain a substituent of prenyl moiety or dimethylpyran (formation from prenyl) in their structures.

2.3. Isolated Flavonoidsin Proliferation and Differentiation of Melanoma Cells

The isolated flavonoids were tested for their antiproliferative capacity using MTT bioassay on cultured B16-F10 cells (Figure 3A). In cell inhibition, the most active component was GF-4 (neoglycyrol), with an IC50 of 17.5 μM, while compounds GF-1, 2, 6, and 9 showed good activities in the range of 26.0–35.8 μM. The other nonprenyl flavonoids, GF-3, 5, 7, 8, and 10, possessed low activities of cell inhibition. Thus, the prenyl could be an important group for inhibition activity of licorice flavonoids in cancer cell growth.
In order to evaluate the differentiating effect of isolated flavonoids, cultured B16-F10 cells were treated with α-MSH (positive drug) or these compounds at two concentrations for 48 h. Accordingly, typical dendrite-like cellular protrusions of cells, induced by GF-1, 2, 4, and 9, were similar with those induced by 20 nM α-melanocyte-stimulating hormone(α-MSH) (Figure 3B) [16]. Surprisingly, GF-6 had no such phenotype induction regardless of its role in cell inhibition (Figure 3B). After comparison of structures of above compounds, the opening of central C-ring in GF-6 could be a possible domain in inducing differentiation in cultured B16-F10 cells.

2.4. Isolated Flavonoids in Melanogenesis

Melanoma cell differentiation is generally accepted to be related to inhibition of cell proliferation, dendritic-like morphology, increased tyrosinase activity, and melanin production [17]. To validate the implications of morphological observations, the amounts of intracellular melanin content, tyrosinase activity and protein were evaluated in B16-F10 cells with the treatment of α-MSH or selected prenylated flavonoids, i.e., GF-1, 4, 6, and 9. The application of α-MSH (positive drug) at 20nM, GF-1, 4, and 9 at 40 μM significantly increased the melanin amounts by about 2-fold, as compared to the control (Figure 4A). However, GF-6 showed no effect. Except for GF-6, the prenylated flavoniods could induce tyrosinase activity in a dose-dependent manner in cultured B16-F10 cells (Figure 4A). The level of tyrosinase protein in the melanoma cells was measured by Western blot analysis. The expression of tyrosinase protein was enhanced to about 2-fold in GF-1, 4, and 9 treated cells (Figure 4B), demonstrating that the melanogenesis promotion was partly mediated by increased tyrosinase in melanoma cells.
To explore potential mechanism of the four prenylated flavonoids (GF-1, 4, 6, and 9) on antiproliferation and differentiation-inducing activities in B16 cells, the activations of MAPKs (ERK 1/2, JNK, and p38), AKT (Protein Kinase B), and PARP (poly ADP-ribose polymerase) signaling pathwayswere probed in the treated B16-F10 cells. These signaling pathways have been identified as important regulators of cell proliferation, differentiation, and tumor development of the malignant phenotype of tumor [18]. The levels of phospho-ERK1/2 (p-ERK1/2) and phospho-JNK (p-JNK) remained unchanged after treatment with the four prenylated flavonoids (Figure 5). However, the level of phospho-p38 (p-p38) was significantly induced by treatment of GF-1 and GF-9, with ~16- and ~13-fold of increase, in respect to the control. In the phosphorylation of p-AKT, only GF-4 showed a reduction (Figure 5). In the cultures, GF-6 showed cell inhibition, but not in cell differentiation, and did not cause phosphorylation of p-ERK1/2, p-JNK, p38, and p-AKT. In contrast, GF-6 application in B16-F10 cells induced the phosphorylation of Cl-PRAP by ~30-fold (Figure 5). Thus, the four tested prenylated flavonoids showed distinction in inducing the signaling cascades, i.e., p-ERK1/2 and p-JNK triggered by GF-1 and GF-9, p-AKT triggered by GF-4, and Cl-PARP triggered by GF-9.
The phosphorylation of p38 could lead to activation of cAMP response element binding protein (CREB) and induction of microphthalmia associated transcription factor (MITF) expression [19]. MITF is a known downstream effector that is required for melanoblast survival, as well as a key regulator to induce genes associated with the differentiation, e.g., tyrosinase [20]. Here, GF-1 and GF-9 markedly increased the phosphorylations of p-p38 and p-CREB, as well as promoting the expression of MITF in dose-dependent manners (Figure 6A).
The PI3K/AKT signaling pathway is another crucial pathway involved in melanoma cell differentiation. Application of GF-4 down-regulated the phosphorylation of p-AKT and PI3K in cultured B16-F10 cells, and this suppression was in a dose-dependent manner (Figure 6B). Glycogen synthase kinase 3 β, a direct downstream target of AKT, phosphorylates MITF and regulates expression of tyrosinase [21]. Therefore, the protein expression of MITF was determined under the treatment of GF-4 in cultured B16-F10 cells. As expected, the level of MITF was induced by 50% after the treatment of GF-4 (Figure 6B). The GF-6-induced Cl-PRAP expression suggested that apoptosis could be involved in the inhibition of B16-F10 cells, triggered by GF-6. In line with an increase of Cl-PRAP, the levels of cleaved caspase-3 and cleaved caspase-9 were markedly induced by treatment of GF-6: the maximal induction over 5-fold and 15-fold could be revealed in cleaved caspase-3 and cleaved caspase-9, respectively (Figure 6C). The increase of apoptotic biomarkers strongly suggested the possible anticancer function of GF-6.

3. Discussion

It has been estimated that 30–40% of cancers can be prevented by dietary or lifestyle condition [22]. Some anticancer drugs currently used in clinics, such as paclitaxel and camptothecin, are derived from natural products. Thus, the search for natural products having anticancer activity represents an interesting area, probably due to its diversity and distinct action mechanism. Flavonoids, commonly found in foods or herbal medicines, are a group of compounds with potential antitumor activities. According to their variations of backbone and substitution, flavonoids can be classified into different subclasses, providing an extremely diverse range of derivatives. Among them, prenylated flavonoids have attracted considerable attention due to their promising and diverse bioactivities [15]. For example, the prenylated substituted chalcones were shown to be cytotoxic in MCF-7, HT-29, and A-2780 cancer cells, whereas the conversion of a chalcone to a favanone resulted in reduced antiproliferative activity [23]. In addition, a prenylated flavonoid, artonol A, exhibited cytotoxic activity against human lung cancer cells [24]. Thus, the substitution in flavonoid structure might possess a profound influence on their antiproliferative effect on cancer cells. As shown here, the proliferation of B16-F10 cells could be significantly inhibited by CH2Cl2 extract of GUR. From this extract, ten flavonoids were isolated, of which five flavonoids with a prenylated group, i.e., GF-1, 2, 4, 6, and 9, displayed effectively cytotoxic activity: these results suggested that the prenyl group could be an indispensable moiety for licorice flavonoids to inhibit B16-F10 cell growth. Considering the structure-activity relationship, the free isoprene flavonoids, e.g., deprenylated compound of GF-9 and kumatakenin B, are showing low antiproliferative effect on B16-F10 cells.
The differentiation process represents a crucial point in progression of many types of cancer. A potential cancer treatment is to promote cancer cell differentiation, and thereafter, to reduce its proliferative capacity: this approach is a novel therapeutic method aiming to modify tumor cells to a slower rate of proliferation, and thus which leads to the loss of its earlier neoplastic attributes [25,26]. In melanoma, the differentiation status of cells could be monitored by melanogenesis, which resulted in the conversion of l-tyrosine to l-dopa by tyrosinase [27]. Indeed, the levels of melanin and tyrosinase are being considered as indicators of differentiated melanoma cells. Our current results supported the contrary action of differentiation against proliferation in melanoma. Here, we have shown the prenylated flavonoids GF-1, 4, and 9 inhibited B16-F10 cell growth, and subsequently which induced cell differentiation. The differentiation, induced by the prenylated flavonoids, was illustrated by morphological change and increase of melanin and tyrosinase. Having a distinction here, GF-6 (licochalcone A) showed inhibitory effect only on cell growth but not differentiation. The GF-6-inhibited cell growth was revealed to be mediated by its apoptotic role. In line to this observation, licochalcone A was shown to activate apoptotic processes in both in vitro and in vivo [28]. Thus, different backbone structure of flavonoids, as revealed here for G.uralensis flavonoids, might have distinct mechanisms to inhibit growth of tumor cells.
Numerous studies have shown that the MAPKs and AKT signaling pathways could play role in survival, proliferation, and differentiation of melanoma [18]. The MAPKs include three well characterized sub-families, i.e., extra cellular signal-regulated kinases -1/2(ERK 1/2), c-jun N-terminal or stress-activated protein kinases (JNK), and p38 mitogen activated protein kinase (p38 MAPK). The activations of ERK (1/2) and JNK were shown to relate with suppression of melanogenesis [20]. Activation of p38 MAPK signaling could upregulate melanin synthesis and induce differentiation by promoting expressions of MITF and tyrosinase [19]. In addition, the activation of AKT could inhibit melanogenesis and differentiation of melanoma [29]. These different lines of evidence support the antiproliferation and differentiation-inducing effects of natural products on melanoma, and the regulation of MAPKs and AKT signaling could be one of key mediators. For example, 5, 7-dimethoxycoumarin, from Citrus limon L., showed potential antigrowth and differentiation-inducing effect on melanoma cell, involving Ras/Raf/MEK/ERK pathway [30]. Lupeol, a lupine-type triterpene from Danelion root, showed significant inhibition on melanoma cell growth both in vitro and in vivo: the effect was trigged by its induction on cell differentiation [31]. Ye [27] reported that three sesquiterpenes, isolated from the largehead atractylode rhizome, induced melanoma cell differentiation and inhibited cell migration through inactivating the signals of Ras/ERK MAPK (for AT-I and AT-II) and PI3K/AKT. Here, we isolated and identified several prenylated flavonoids including isoflavone, flavone, chalcone, and coumarin. Interestingly, prenylatedflavone (GF-1) and prenylatedisoflavone (GF-9) could induce activation of p38 MAPK pathway, while prenylated coumarin (GF-4) showed inhibition on PI3K/AKT signaling. The prenylated chalcone GF-6 did not affect cell differentiation, but which induced melanoma cell apoptosis with activation of proteins in caspase-mediated signaling pathway. This result was in good agreement with recent literature [32]. However, a more detailed mechanism by which the prenylated flavonoids in melanoma cell differentiation and cell proliferation are waiting for further elucidation.

4. Material and Methods

4.1. Plant Material

The roots of G. uralensis (GUR) were collected in Minqin County, Gansu province, China in September 2016. Voucher specimen (No. 20160919) was stored in a dry and dark room and deposited at Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization (Nanjing University of Chinese Medicine). The authentication of GUR was carried out by Prof. Qinan Wu from Nanjing University of Chinese Medicine, Nanjing, China.

4.2. Extraction and Isolation

4.2.1. Phytochemical Extractions of G. uralensis Roots

The water extract of GUR (GURwater) was prepared by boiling GUR crude materials (100 g of fine powder) with water (1000 mL, 1 h) at 100 °C, extracted twice. Likewise, 100 g GUR powder was extracted with ethanol (1000 mL, 1 h) at 80 °C, extracted twice to obtain the ethanol extract (GUEtOH). To prepare GUR dichloromethane extract (GURCH2Cl2), 100 g of GUR powder was boiled at 50 °C (1000 mL, 1 h) with CH2Cl2, extracted twice. The fractions were concentrated in vacuumand then freeze-dried to obtain loose fine powder.
HPLC chromatograms of different GUR extracts (GURwater, GUREtOH, and GURCH2Cl2) were carried out using an Agilent 1100 HPLC system (Agilent Technologies, Santa Clara, CA, USA). An Agilent RP C18 column (250 × 4.6 mm id, 5 μm) was used. Samples were separated using a gradient mobile phase consisting of 0.2% (v/v) formic acid water (A) and acetonitrile (B). The gradient conditions were: 18–25% B at 0–10 min, 25–45% B at 10–30 min, 45–70% B at 30–45 min, and 70% B at 45–60 min. The flow rate was set at 1.0 mL/min. The detection wavelength was 254 nm. The sample concentration was 1 mg/mL, and injection volume was 10 μL.

4.2.2. Isolation and Identification of Flavonoids

GUR (dry weight, 5 kg) were exhaustively extracted two times with dichloromethane (30 L × 2, each extraction for 1 h). The extractives were combined and concentrated in vacuo. The residue (a total of about 105 g) was then separated to three fractions (Fr. A–C) by normal-phase silica gel CC (800 g, 200–300 mesh Silica) using a step-wise gradient elution of CH2Cl2-MeOH (100:0–80:20, v/v).Fr. A (about 6.5g) applied to middle pressure liquid chromatography (MPLC, BUCHI Chromatography B-688, Switzerland) on ODS column with a gradient solution of MeOH-H2O (60:40–70:30, v/v) as elution to give GF-1 (43 mg) and GF-2 (18 mg). Fr. B (about 31.6 g) was subjected to MPLC silica gel using a stepwise gradient elution of CH2Cl2-MeOH (95:5–90:10, v/v) to provide the two sub-fractions Fr. B1 and Fr. B2. Fr. B1 was subsequently purified by MPLC chromatography over RP-18 silica gel column (400 g, 25–50 μm, 4.5 × 50 cm) eluted with MeOH-H2O (70:30) to afford GF-3 (55 mg), GF-4 (102 mg) and GF-5 (31 mg). Fr. B2 was subjected to MPLC with a ODS column (400 g, 25–50 μm, 4.5×50 cm) to give GF-6 (26 mg) and GF-7 (34 mg). Fr. C (about 9.4 g) was applied to MPLC chromatography on ODS column with a gradient solution of MeOH-H2O (60:40–70:30, v/v) as elution to afford GF-8 (23 mg), GF-9 (42 mg), and GF-10 (67 mg). The purified compounds were characterized by LC-MS and NMR analyses. The MS spectra were recorded on an Agilent 1200 HPLC/Q-TOF mass spectrometer instrument (Agilent) in positive ion mode. The specimens were dissolved in DMSO-d6 (dimethylsulphoxide), and 1H NMR and 13C NMR were assayed with ASR-500 or ASR-300 NMR spectrometer, nuclear magnetic resonance, TMS was used as an internal standard.

4.3. Cell Culture

The melanoma B16-F10 cell line was obtained from American Type Culture Collection (ATCC, Manassas, Virginia, VA, USA). The cells were maintained in Dulbecco’s modified Eagle’s medium containing 10% fetal bovine serum, 100 units/mL penicillin and 100 μg/mL streptomycin in a humidified CO2 (5%) incubator at 37 °C. All reagents for cell cultures were purchased from Invitrogen (Carlsbad, California, CA, USA).

4.4. Antiproliferative Activity Assay

The antiproliferative activities of GUR extracts and flavonoids were investigated using the MTT assay [14]. Firstly, B16-F10 cells were cultured in 96-well plates at approximately 7.5 × 103 cells per well and incubated for 12 h. Then cells were treated with different concentrations of GUR extracts (5, 10, 25, 50, and 100 μg/mL) or GUR flavonoids (10, 20, 40, 60, and 80 μM). After incubation of 48 h, MTT solution (5 mg/mL in PBS) was added to each well, and cells were incubated at 37 °C for 4 h. Subsequently, 150 μL DMSO was added to each well, and the plate was put on a shaker for 5 min, the absorbance were measured at 570 nm using a fluorescence plate reader (Thermo scientific, Waltham, MA, USA). Inhibition percentage (%) was calculated according to the following formula: Inhibition percentage of cell viability (%) = [1−(OD treated well/OD control well)] × 100%. The IC50 value was calculated using the SPSS v. 22.0 Statistics Software (IBM Corp., Armonk, New York, NY, USA).

4.5. Morphological and Differentiation Analysis

B16-F10 cellswere cultured in 35-mm dishes (2 × 105 cells/well) and treatedwith different concentration of GUR extracts (0, 50 μg/mL), its flavonoids(0, 20, 40 μM), or α-MSH (20 nM) for 48 h.Afterthe treatment, the morphological changes were observed under a microscope (Olympus, Japan). Differentiation and mature phenotypes were characterized by formation of dendrite-like cellular protrusions. Differentiation ratio (%) was expressed as the percentage of cells with cytoplasmic extension longer than three cellular bodies in relation tothe total number of cells [33,34].

4.6. Measurement of Tyrosinase Activity

Measurement of tyrosinase activity was performed according to a previously published method with slight modifications [27]. In brief, cells were cultured in 6-wells/plate at a density of 2 × 105 cells/well, and treated with different concentrations of GUR flavonoids (0, 20, and 40 μM, respectively) or α-MSH (20 nM) for 48 h. After the treatment, the cells were washed with ice-cold PBS twice, lysed at 4 °C for 30 min in RIPA lysis buffer (150 mMNaCl, 1 mM EDTA, 1 mM EGTA, 50 mM Tris–Cl, 0.35% w/v sodium-deoxycholate, 1 mM phenylmethylsulfonyl fluoride, 1% v/v NP-40, 1 mM NaF, 1 mM Na3VO4, pH 7.4) containing a protease-inhibitor cocktail. Each lysate was centrifuged at 15,000× g for 30 min. Then, 50 μL of supernatant was added to 100 μL of 0.1% L-DOPA in PBS (pH = 6.8) in a well on a 96-well plate. After 2 h of incubation at 37 °C, the absorbance at 475 nm was measured. Meanwhile, the protein concentration of each lysate was determined by Bio-Rad protein assay. Tyrosinase activity was normalized with protein amount.

4.7. Determination of Melanin Content

Cellular melanin content was measured as described previously with a slight modification [14]. B16-F10 cells (2 × 105 cells) were placed in 6-well/plate and treated with different concentrations of GUR flavonoids (0, 20, and 40 μM, respectively) or α-MSH (20 nM) to determinate melanin content of B16-F10 cells. After incubation for 48 h, the cells were washed twice with PBS, then cells were collected after digestion with 0.05% Trypsin-EDTA for cell counting. Then 1 × 105 cells per well were dissolved in 150 μL of 1 M NaOH containing 10% DMSO for 1 h at 80 °C. The lysate was centrifuged at 16,000× g for 20min. Then, 100 μL supernatant was transferred to 96-well plates. The absorbance of each well was measured at 490 nm by fluorescence plate reader.

4.8. Western Blot Analysis

Western blot was performed as previously described [35]. B16-F10 Cells cultured in 100-mm dishes were treated with the required GUR flavonoids concentration of 0, 20, and 40 μM or α-MSH (20 nM) for 48 h. Then, cells were collected and proteins were extracted with RIPA lysis buffer containing a protease-inhibitor cocktail. The total protein concentrations were measured using the Bradford method, and the normalized protein samples were added to 4× sample buffer, then boiled and denatured. Equal amounts of proteins were separated by SDS-PAGE and then transferred to nitrocellulose membranes. The membranes were blocked and then probed with indicated primary antibodies, respectively, with anti-GAPDH (1:5000), anti-tyrosinase (1:200), anti-ERK1/2 (1:2500), anti-p-ERK1/2 (1:1000), anti-JNK (1:2500), anti-p-JNK (1:1000), anti-p38 (1:2500), anti-p-p38 (1:1000), anti-AKT (1:2500), anti-p-AKT (1:1000), anti-cleaved-PARP (1:1000), anti-P-CREB (1:1000), anti-CREB (1:1000), anti-MITF (1:200), anti-PI3K(P85) (1:1000), anti-caspase 3 (1:2500), anti-caspase 9 (1:2500), anti-cleaved-caspase 3 (1:1000), anti-cleaved-caspase 9 (1:1000), at 4 °C overnight. Anti-tyrosinase and anti-MITF antibodies were purchased from Santa Cruz. Biotech (Santa Cruz, California, CA, USA), others were from Cell Signaling Technology (Cell Signaling, Danvers, Massachusetts, MA, USA). All antibodies were diluted with 5% BSA in TBST buffer. The blots were rinsed and then incubated with secondary antibodies (anti-mouse antibody or anti-rabbit antibody, 1:5000, Cell Signaling Technology). Reactive bands were visualized using ECL (Thermo Fisher Scientific; Waltham, MA, USA) and then calibrated by Chemidoc Imaging System (Bio-Rad; Hercules, California, CA, USA).

4.9. Statistical Analysis

The significant difference among groups was statistically performed by one-way analysis of variance (ANOVA) combined with Tukey’stest by SPSS v. 22.0 program (IBM Corp., Armonk, New York, NY, USA). Probability value less than 0.05 (p < 0.05) was considered to be statistically significant. Data are expressed as the means±standard error of mean (SEM) of at least three independent experiments.

5. Conclusions

Here, we provided different lines of evidence that the dichloromethane extract of G. uralensis roots has potential antiproliferation and differentiation-inducing activities in cultured B16-F10 melanoma cells. Prenylated flavoniods were isolated and demonstrated to be the active constituents within the extract of G. uralensis roots. These prenylated flavonoids have different backbone structures, and thus each of them has distinct activity in inhibiting cancer cell growth. The present results provided the molecular basis for using nonpolar extract of G. uralensis roots, and the identified bioactive prenylated flavonoids could be further developed for the prevention and/or treatment of melanoma cancer.

Supplementary Materials

Supplementary materials can be found at https://www.mdpi.com/1422-0067/19/8/2422/s1.

Author Contributions

K.W.K.T. and T.T.X.D. conceived and designed the experiments; Y.Z. performed the experiments, analyzed the results, and made figures and tables; M.Y. and M.X.L. performed the experiments; H.W. and G.P. contributed to designing the experiments; K.W.K.T. and Y.Z. wrote the paper.

Acknowledgements

This work was supported by A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Priority Academic Program Development of Jiangsu Higher Education Institutions, and Jiangsu Oversea Research & Training Program. Shenzhen Science and Technology Committee Research Grant (CKFW2,016,082,916,015,476; JCYJ20,170,413,173,747,440; JCYJ20,160,229,205,726,699; JCYJ20, 160,229,205,812,004; JCYJ20,160,229,210,027,564; ZDSYS201,707,281,432,317 and 20,170,326). We also thank Qinan Wu of Nanjing University of Chinese Medicine for identification of the plant material.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Birari, R.B.; Gupta, S.; Mohan, C.G.; Bhutani, K.K. Antiobesity and lipid lowering effects of Glycyrrhiza chalcones: Experimental and computational studies. Phytomedicine. 2011, 18, 795–801. [Google Scholar] [CrossRef] [PubMed]
  2. Fiore, C.; Eisenhut, M.; Ragazzi, E.; Zanchin, G.; Armanini, D. A history of the therapeutic use of liquorice in Europe. J. Ethnopharmacol. 2005, 99, 317–324. [Google Scholar] [CrossRef] [PubMed]
  3. Kuang, Y.; Lin, Y.; Li, K.; Song, W.; Ji, S.; Qiao, X.; Zhang, Q.Y.; Ye, M. Screening of hepatoprotective compounds from licorice against carbon tetrachloride and acetaminophen induced HepG2 cells injury. Phytomedicine. 2017, 34, 59–66. [Google Scholar] [CrossRef] [PubMed]
  4. Fang, S.Q.; Qu, Q.Y.; Zheng, Y.F.; Zhong, H.H.; Shan, C.X.; Wang, F.; Li, C.Y.; Guo, P.P. Structural characterization and identification of flavonoid aglycones in three Glycyrrhiza species by liquid chromatography with photodiode array detection and quadrupole time-of-flight mass spectrometry. J. Sep. Sci. 2016, 39, 2068–2078. [Google Scholar] [CrossRef] [PubMed]
  5. Fu, Y.; Chen, J.; Li, Y.J.; Zheng, Y.F.; Li, P. Antioxidant and anti-inflammatory activities of six flavonoids separated from licorice. Food Chem. 2013, 141, 1063–1071. [Google Scholar] [CrossRef] [PubMed]
  6. Cho, H.J.; Lim, S.S.; Lee, Y.S.; Kim, J.S.; Lee, C.H.; Kwon, D.Y.; Park, J.H.Y. Hexane/ethanol extract of Glycyrrhiza uralensis licorice exerts potent anti-inflammatory effects in murine macrophages and in mouse skin. Food Chem. 2010, 141, 959–966. [Google Scholar] [CrossRef]
  7. Huo, X.W.; Liu, D.Y.; Gao, L.; Li, L.Y.; Cao, L. Flavonoids extracted from licorice prevents Colitis-associated carcinogenesis in AOM/DSS mouse model. Int. J. Mol. Sci. 2016, 17, 1343. [Google Scholar] [CrossRef] [PubMed]
  8. Hoang, M.T.; Echenfield, L.F. The rising incidence of melanoma in children and adolescents. Dermatol. Nurs. 2000, 121, 192–193. [Google Scholar]
  9. Lo, J.A.; Fisher, D.E. Melanoma pathogenesis. Cancer Drug Discov. Develop. 2015, 82, 25–45. [Google Scholar]
  10. Parka, H.J.; Hana, E.S.; Park, D.K. The ethyl acetate extract of PGP (Phellinuslinteus grown on Panax ginseng) suppresses B16F10 melanoma cell proliferation through inducing cellular differentiation and apoptosis. J. Ethnopharmacol. 2010, 132, 115–121. [Google Scholar] [CrossRef] [PubMed]
  11. Van den, B.; Verdegaal, E.M.; De Miranda, N.F. Cancer immunotherapy: Broadening the scope of targetable tumours. Open Biol. 2018. [Google Scholar] [CrossRef] [PubMed]
  12. Thomas, K.; Rebecca, W.K.; Rafael, C.; Brian, G. Malignant melanoma: Diagnostic and management––Update. Plast. Reconstr. Surg. 2018, 142, 202–216. [Google Scholar]
  13. Skandrani, P.A.; Simon, A.; Ghedira, K.; Chekir-Ghedira, L. Chloroform extract from Moricandiaarvensis inhibits growth of B16-F0 melanoma cells and promotes differentiation in vitro. Cell Prolif. 2010, 43, 471–479. [Google Scholar] [CrossRef] [PubMed]
  14. Wang, D.; Xu, W.; Chen, X.; Han, J.; Yu, L.; Gao, C.; Hao, W.; Liu, X.; Zheng, Q.; Li, D. Icariin induces cell differentiation and cell cycle arrest in mouse melanoma B16 cells via Erk1/2-p38-JNK-dependent pathway. Oncotarget. 2017, 8, 99504–99513. [Google Scholar] [CrossRef] [PubMed]
  15. Chen, X.; Mukwaya, E.; Wong, M.; Zhang, Y.A. systematic review on biological activities of isoprenyl flavonoids. Pharm. Biol. 2013, 52, 655–660. [Google Scholar] [CrossRef] [PubMed]
  16. Keishi, H.; Kyoko, I.; Kazuyuki, H.; Tomokazu, K. Differentiation-inducing activity of lupeol, a lupine-type triterpene from Chinese Dandelion root (Hokouei-kon), on a mouse melanoma cell line. Biol. Pharm. Bull. 2000, 23, 962–967. [Google Scholar]
  17. Puri, N.; Eller, M.S.; Byers, H.R.; Dykstra, S.; Kubera, J.; Gilchrest, B.A. Telomere-based DNA damage responses: A new approach to melanoma. FASEB J. 2004, 18, 1373–1381. [Google Scholar] [CrossRef] [PubMed]
  18. Russo, AE.; Torrisi, E.; Bevelacqua, Y.; Perrotta, R.; Libra, M.; Mccubrey, JA.; Spandidos, DA.; Stivala, F.; Malaponte, G. Melanoma: Molecular pathogenesis and emerging target therapies (Review). Int. J. Oncol. 2009, 34, 1481–1489. [Google Scholar] [PubMed]
  19. Hata, K.; Hori, K.; Takahashi, S. Role of p38 MAPK in lupeol-induced B16 2F2 mouse melanoma cell differentiation. J. Biochem. 2003, 134, 441–445. [Google Scholar] [CrossRef] [PubMed]
  20. Jin, M.L.; Park, S.Y.; Kim, Y.H.; Park, G.; Son, H.J.; Lee, S.J. Suppression of α-MSH and IBMX-induced melanogenesis by cordycepin via inhibition of CREB and MITF, and activation of PI3K/Akt and ERK-dependent mechanisms. Int. J. Mol. Sci. 2012, 29, 119–124. [Google Scholar]
  21. Takeda, K. Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance. Hum. Mol. Genet. 2000, 9, 125–132. [Google Scholar] [CrossRef] [PubMed][Green Version]
  22. Neuhouser, M.L. Review: Dietary flavonoids and cancer risk: Evidence from human population studies. Nutr. Cancer. 2004, 50, 1–7. [Google Scholar] [CrossRef] [PubMed]
  23. Miranda, C.; Stevens, J.; Helmrich, A.; Henderson, M.; Rodriguez, R.; Yang, Y.; Deinzer, M.; Barnes, D.; Buhler, D. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humuluslupulus) in human cancer cell lines. Food Chem. Toxicol. 1999, 37, 271–285. [Google Scholar] [CrossRef]
  24. Ko, H.; Lu, Y.; Yang, S.; Won, S.; Lin, C. Cytotoxic prenyl flavonoids from Artocarpuselasticus. J. Nat. Prod. 2005, 68, 1692–1695. [Google Scholar] [CrossRef] [PubMed]
  25. Leszczyniecka, M.; Roberts, T.; Dent, P.; Grant, S.; Fisher, P.B. Differentiation therapy of human cancer: Basic science and clinical applications. Pharmacol. Ther. 2001, 90, 105–156. [Google Scholar] [CrossRef]
  26. Serafino, A.; Sinibaldi, V.P.; Lazzarino, G.; Tavazzi, B.; Rasi, G.; Pierimarchi, P.; Andreola, F.; Moroni, G.; Galvano, G.; Galvano, F.; et al. Differentiation of human melanoma cells induced by cyanidin-3-O-β-glucopyranoside. FASEB J. 2004, 18, 1940–1942. [Google Scholar] [CrossRef] [PubMed]
  27. Ye, Y.; Chou, G.X.; Wang, H.; Chu, J.H.; Fong, W.F.; Yu, Z.L. Effects of sesquiterpenes isolated from LargeheadAtractylodes Rhizome on growth, migration, and differentiation of B16 melanoma cells. Integr. Cancer Ther. 2010, 10, 92–100. [Google Scholar]
  28. Tsai, J.; Lee, C.; Ying, T.; Lin, C.; Lin, C.; Hsueh, J.; Hsieh, Y. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells. Oncotarget 2015, 6, 28851–28866. [Google Scholar] [CrossRef] [PubMed][Green Version]
  29. Jeong, H.; Gu, G.E.; Jo, A.R.; Bang, J.S.; Yun, H.; Baek, K.J.; Kwon, N.S.; Park, K.C.; Kim, D.S. Baicalin-induced Akt activation decreases melanogenesis through downregulation of microphthalmia-associated transcription factor and tyrosinase. Eur. J. Pharmacol. 2015, 761, 19–27. [Google Scholar] [CrossRef] [PubMed]
  30. Alesiani, D.; Cicconi, R.; Mattei, M.; Montesano, C.; Bei, R.; Canini, A. Cell cycle arrest and differentiation induction by 5, 7-dimethoxycoumarin in melanoma cell lines. Int. J. Oncol. 2008, 32, 425–434. [Google Scholar] [CrossRef] [PubMed]
  31. Ogihara, K.; Naya, Y.; Okamoto, Y.; Hata, K. Differentiation-inducing and antiproliferative activities of lupeol on canine melanoma cells. SpringerPlus. 2014, 3, 632–638. [Google Scholar] [CrossRef] [PubMed]
  32. Yuan, X.; Li, D.; Zhao, H.; Jiang, J.; Wang, P.; Ma, X.; Sun, X.; Zheng, Q. Licochalcone A-Induced Human Bladder Cancer T24 Cells apoptosis triggered by mitochondria dysfunction and endoplasmic reticulum stress. BioMed. Res. Int. 2013, 2013, 474272. [Google Scholar] [CrossRef] [PubMed]
  33. Ren, K.K.; Wang, H.Z.; Xie, L.P.; Chen, D.W.; Liu, X.; Sun, J.; Nie, Y.C.; Zhang, R.Q. The effects of oridonin on cell growth, cell cycle, cell migration and differentiation in melanoma cells. J. Ethnopharmacol. 2006, 103, 176–180. [Google Scholar] [CrossRef] [PubMed]
  34. Naliwaiko, K.; Luvizon, A.C.; Donatti, L.; Chammas, R.; Mercadante, A.F.; Zanata, S.M.; Nakao, L.S. Guanosine promotes B16F10 melanoma cell differentiation through PKC–ERK 1/2 pathway. Chem. Biol. Interact. 2008, 173, 122–128. [Google Scholar] [CrossRef] [PubMed]
  35. Lou, J.S.; Yan, L.; Bi, C.W.; Chan, G.K.; Wu, Q.Y.; Liu, Y.; Wang, H.Y.; Yao, P.; Du, C.Y.; Dong, T.T.; et al. Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling. Sci. Rep. 2016, 6, 31926. [Google Scholar] [CrossRef] [PubMed][Green Version]
Ijms 19 02422 g001a 550Ijms 19 02422 g001b 550
Figure 1. Effects of different extracts of G. uralensis root in antiproliferation and differentiation-inducing activities in B16-F10 cells. (A) HPLC chromatograms of different extracts, all at 1 mg/mL, from GUR, i.e., GUwater (water extract of GUR), GUEtOH (EtOH extract of GUR), and GUCH2Cl2 (CH2Cl2 extract of GUR). (B) Melanoma B16-F10 cells were treated with different extracts of GUR or with medium of 0.1% DMSO (dimethylsulphoxide) for 48 h, after which cells were counted under MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide) assay. (C) Melanoma B16-F10 cells were treated with GUwater, GUEtOH, and GUCH2Cl2 (50 μg/mL, respectively) for 48 h (left panel). At least 150 cells were counted for cells with dendrite longer than 3× cellular body, as differentiated cells (right panel). Data are expressed as percentage of control, in means ± SEM of 3 independent experiments. * p < 0.05, ** p < 0.01, compared with control; ## p < 0.01, compared with other extracts.
Figure 1. Effects of different extracts of G. uralensis root in antiproliferation and differentiation-inducing activities in B16-F10 cells. (A) HPLC chromatograms of different extracts, all at 1 mg/mL, from GUR, i.e., GUwater (water extract of GUR), GUEtOH (EtOH extract of GUR), and GUCH2Cl2 (CH2Cl2 extract of GUR). (B) Melanoma B16-F10 cells were treated with different extracts of GUR or with medium of 0.1% DMSO (dimethylsulphoxide) for 48 h, after which cells were counted under MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide) assay. (C) Melanoma B16-F10 cells were treated with GUwater, GUEtOH, and GUCH2Cl2 (50 μg/mL, respectively) for 48 h (left panel). At least 150 cells were counted for cells with dendrite longer than 3× cellular body, as differentiated cells (right panel). Data are expressed as percentage of control, in means ± SEM of 3 independent experiments. * p < 0.05, ** p < 0.01, compared with control; ## p < 0.01, compared with other extracts.
Ijms 19 02422 g001aIjms 19 02422 g001b
Ijms 19 02422 g002a 550Ijms 19 02422 g002b 550
Figure 2. Structures of flavonoids isolated from CH2Cl2 extract of G. uralensis root.
Figure 2. Structures of flavonoids isolated from CH2Cl2 extract of G. uralensis root.
Ijms 19 02422 g002aIjms 19 02422 g002b
Ijms 19 02422 g003a 550Ijms 19 02422 g003b 550
Figure 3. Antiproliferation and differentiation activity of G. uralensis flavonoids on B16-F10 cells. (A) Melanoma B16-F10 cells were treated with 10 flavonoids (GF-1–GF-10) at different concentrations or with medium (0.1% DMSO) for 48 h, after which the cells were assayed under MTT assay. IC50 value was calculated using SPSS statistics software. (B) Melanoma B16-F10 cells were treated with 10 flavonoids (GF-1–GF-10) at 20 or 40 μM, positive drug (α-MSH) at 20 nM or medium (0.1% DMSO) for 48 h. At least 150 cells were counted for dendrite longer than 3× cell body, as differentiated cell (upper panel). Data are expressed as percentage of control, as means ± SEM (n = 3) * p < 0.05, ** p < 0.01, compared with control. Morphological of B16-F10 cells treated with selected flavonoids at 40 μM (lower panel).
Figure 3. Antiproliferation and differentiation activity of G. uralensis flavonoids on B16-F10 cells. (A) Melanoma B16-F10 cells were treated with 10 flavonoids (GF-1–GF-10) at different concentrations or with medium (0.1% DMSO) for 48 h, after which the cells were assayed under MTT assay. IC50 value was calculated using SPSS statistics software. (B) Melanoma B16-F10 cells were treated with 10 flavonoids (GF-1–GF-10) at 20 or 40 μM, positive drug (α-MSH) at 20 nM or medium (0.1% DMSO) for 48 h. At least 150 cells were counted for dendrite longer than 3× cell body, as differentiated cell (upper panel). Data are expressed as percentage of control, as means ± SEM (n = 3) * p < 0.05, ** p < 0.01, compared with control. Morphological of B16-F10 cells treated with selected flavonoids at 40 μM (lower panel).
Ijms 19 02422 g003aIjms 19 02422 g003b
Ijms 19 02422 g004 550
Figure 4. The G. uralensis flavonoids induce the amounts of melanin content, tyrosinase activity, and tyrosinase expression of B16-F10 melanoma cells. (A) B16-F10 cells were treated with indicated concentrations of selected flavonoids (GF-1, 4, 6, and 9) or with α-MSH at 20 nM for 48 h. The amounts of melanin (left panel) and tyrosinase activity (right panel) were determined. (B) The level of tyrosinase protein (~91 kDa) in the melanoma cells was measured by Western blot (left panel). The amount of tyrosinase was qualified against GAPDH (~37 kDa) (right panel). Data are expressed as percentage of control, in means ± SEM (n = 3). * p < 0.05, ** p < 0.01, compared with control.
Figure 4. The G. uralensis flavonoids induce the amounts of melanin content, tyrosinase activity, and tyrosinase expression of B16-F10 melanoma cells. (A) B16-F10 cells were treated with indicated concentrations of selected flavonoids (GF-1, 4, 6, and 9) or with α-MSH at 20 nM for 48 h. The amounts of melanin (left panel) and tyrosinase activity (right panel) were determined. (B) The level of tyrosinase protein (~91 kDa) in the melanoma cells was measured by Western blot (left panel). The amount of tyrosinase was qualified against GAPDH (~37 kDa) (right panel). Data are expressed as percentage of control, in means ± SEM (n = 3). * p < 0.05, ** p < 0.01, compared with control.
Ijms 19 02422 g004
Ijms 19 02422 g005 550
Figure 5. The G. uralensis flavoniods induce signaling of ERK (1/2), JNK, p38, AKT, and PARP. B16-F10 cells were treated with selected flavonoids (GF-1, 4, 6,and 9) at concentration of 40 μM or with medium (0.1% DMSO) for 48 h. Cell lysates were analyzed by Western blotting with the indicated antibodies (left panel). Photographs of the chemiluminescent detection of the blots, which were representative of three independent experiments, are shown (right panel). The relative abundance of each band to their own GAPDH was quantified, and the control levels were set at 1.0. Data are expressed as percentage of control, in means ± SEM (n = 3). ** p < 0.01, compared with control.
Figure 5. The G. uralensis flavoniods induce signaling of ERK (1/2), JNK, p38, AKT, and PARP. B16-F10 cells were treated with selected flavonoids (GF-1, 4, 6,and 9) at concentration of 40 μM or with medium (0.1% DMSO) for 48 h. Cell lysates were analyzed by Western blotting with the indicated antibodies (left panel). Photographs of the chemiluminescent detection of the blots, which were representative of three independent experiments, are shown (right panel). The relative abundance of each band to their own GAPDH was quantified, and the control levels were set at 1.0. Data are expressed as percentage of control, in means ± SEM (n = 3). ** p < 0.01, compared with control.
Ijms 19 02422 g005
Ijms 19 02422 g006 550
Figure 6. G. uralensis flavonoids induce differentiation or apoptosis via different signaling pathways in B16-F10 cells. B16-F10 cells were treated with various concentrations of selected flavonoids at concentration of 20 and 40 μM for 48 h, after which protein expression in total cells were assayed by Western blot analysis. (A) GF-1 and GF-9 induced phosphorylations of p 38 (~38 kDa) and p-CREB (~43 kDa), as well as expression of and MITF (~60 kDa). (B) GF-4 induced protein expression of p-AKT (~60 kDa), PI3K(~85 kDa), and MITF (~60 kDa). (C) GF-6 induced expression of Cl-PARP(~89 kDa), Cl-Casp 9(~37 kDa), and Cl-Casp 3(~19 kDa). The relative abundance of each band to their own GAPDH was quantified, and the control levels were set at 1.0 (lower panel). Data are expressed as percentage of control, in means ± SEM (n = 3).* p < 0.05, ** p < 0.01, compared with control.
Figure 6. G. uralensis flavonoids induce differentiation or apoptosis via different signaling pathways in B16-F10 cells. B16-F10 cells were treated with various concentrations of selected flavonoids at concentration of 20 and 40 μM for 48 h, after which protein expression in total cells were assayed by Western blot analysis. (A) GF-1 and GF-9 induced phosphorylations of p 38 (~38 kDa) and p-CREB (~43 kDa), as well as expression of and MITF (~60 kDa). (B) GF-4 induced protein expression of p-AKT (~60 kDa), PI3K(~85 kDa), and MITF (~60 kDa). (C) GF-6 induced expression of Cl-PARP(~89 kDa), Cl-Casp 9(~37 kDa), and Cl-Casp 3(~19 kDa). The relative abundance of each band to their own GAPDH was quantified, and the control levels were set at 1.0 (lower panel). Data are expressed as percentage of control, in means ± SEM (n = 3).* p < 0.05, ** p < 0.01, compared with control.
Ijms 19 02422 g006
Table
Table 1. Table of 13C NMR Spectroscopic data of 10 flavonoid compounds in DMSO-d6.
Table 1. Table of 13C NMR Spectroscopic data of 10 flavonoid compounds in DMSO-d6.
GF-1GF-2GF-3GF-4GF-5GF-6GF-7GF-8GF-9GF-10
C-1 113.5 125.7
C-2155.7155.1162.5157.9153.0158.278.9131.1162.2155.8
C-3120.5122.1104.4102.7124.299.943.1115.8104.4137.7
C-4180.6176.0176.2158.6174.5159.6190.0160.3176.2178.0
C-4a104.6116.216.1100.2127.2 113.5 115.8105.1
C-5161.8127.2126.4154.3116.6126.5128.3115.8124.5160.9
C-698.8115.3114.7120.1115.0127.7110.5131.1127.297.6
C-7164.1162.8160.6160.0162.5 164.6 160.3165.0
C-893.6102.0102.499.7102.0 102.5 101.792.2
C-8a157.7157.5157.3153.4158.9 163.1 155.6160.2
C-α 117.8 144.2
C-β 138.7 117.4
C-γ 187.3 191.5
C-1′111.2112.7121.7114.7123.1129.6129.3112.9121.9120.4
C-2′151.2151.3128.0156.6130.0130.6128.2165.8127.9130.1
C-3′109.7110.1115.899.0113.5115.2115.1102.5115.8115.6
C-4′153.6153.5162.4157.4157.4161.6157.6165.4160.5156.2
C-5′107.4107.6115.8114.5113.5115.2115.1108.0115.8115.6
C-6′131.3130.9128.0120.9130.0130.6128.2132.7127.9130.1
C-1″ 22.5 39.5 27.5
C-2″75.475.4 122.9 147.5 121.8
C-3″128.8128.8 131.4 109.9 132.3
C-4″116.9117.0 18.2 26.9 25.5
C-5″27.427.5 25.9 26.9 17.6
C-6″27.427.5
2-OCH3 55.4
3-OCH3 56.0
4′-OCH3 55.1
5-OCH3 62.8
7-OCH3 59.6

Share and Cite

MDPI and ACS Style

Zheng, Y.; Wang, H.; Yang, M.; Peng, G.; Dong, T.T.X.; Xu, M.L.; Tsim, K.W.K. Prenylated Flavonoids from Roots of Glycyrrhiza uralensis Induce Differentiation of B16-F10 Melanoma Cells. Int. J. Mol. Sci. 2018, 19, 2422. https://doi.org/10.3390/ijms19082422

AMA Style

Zheng Y, Wang H, Yang M, Peng G, Dong TTX, Xu ML, Tsim KWK. Prenylated Flavonoids from Roots of Glycyrrhiza uralensis Induce Differentiation of B16-F10 Melanoma Cells. International Journal of Molecular Sciences. 2018; 19(8):2422. https://doi.org/10.3390/ijms19082422

Chicago/Turabian Style

Zheng, Yunfeng, Huaiyou Wang, Min Yang, Guoping Peng, Tina Ting Xia Dong, Miranda Li Xu, and Karl Wah Keung Tsim. 2018. "Prenylated Flavonoids from Roots of Glycyrrhiza uralensis Induce Differentiation of B16-F10 Melanoma Cells" International Journal of Molecular Sciences 19, no. 8: 2422. https://doi.org/10.3390/ijms19082422

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop